Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-071291
Filing Date
2015-12-16
Accepted
2015-12-16 16:51:58
Documents
1
Period of Report
2015-12-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v427036_4.html 4  
1 OWNERSHIP DOCUMENT v427036_4.xml 4 3860
  Complete submission text file 0001144204-15-071291.txt   5303
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 151291469